# AC6 Gene Transfer for CHF

> **NCT00787059** · PHASE1,PHASE2 · COMPLETED · sponsor: **Hammond, H. Kirk, M.D.** · enrollment: 56 (actual)

## Conditions studied

- Congestive Heart Failure

## Interventions

- **DRUG:** Ad5.hAC6
- **DRUG:** Sucrose (3%)

## Key facts

- **NCT ID:** NCT00787059
- **Lead sponsor:** Hammond, H. Kirk, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2015-01
- **Final completion:** 2017-11-16
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2018-02-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00787059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00787059, "AC6 Gene Transfer for CHF". Retrieved via MORVS 2026-10-25 from https://api.morvs.ai/clinical/NCT00787059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*